ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Lipids"

  • 2019 American Transplant Congress

    Effects of Statin Use on Cardiovascular Outcome in Patients with Renal Transplantation

    J. Kim1, K. Park1, S. Park1, M. Yu2, Y. Kim1, K. Kim1, M. Park3, H. Lee1

    1Seoul National University Hospital, Seoul, Korea, Republic of, 2Hanyang University Guri Hospital, Gyeonggi-do, Korea, Republic of, 3Samsung Medical Center, Seoul, Korea, Republic of

    *Purpose: Cardiovascular disease is the main cause of death among patients with end-stage renal disease (ESRD). Statin, HMG-CoA reductase inhibitor, is well known to significantly…
  • 2019 American Transplant Congress

    Gene Expression Profiles in CD8+ T Cells in Chronic Antibody-Mediated Rejection (CAMR) of Kidney Transplantation

    P. Pontrelli1, F. Rascio2, M. Accetturo1, G. Castellano1, S. Simone1, G. Stallone2, L. Gesualdo1, G. Grandaliano2

    1Department of Emergency, and Organ Transplantation, Nephrology, Dialysis and Transplantation Unit, University of Bari, Bari, Italy, 2Dept. of Surgical and Medical Sciences, Nephrology Unit, University of Foggia, Foggia, Italy

    *Purpose: CAMR is the main cause of chronic graft injury and subsequent graft loss. Most of the studies on the subject focused their attention to…
  • 2019 American Transplant Congress

    Sphingosine 1-Phosphate Receptors and CCR7 Sequentially Coordinate T Cell Migration

    Y. Xiong1, W. Piao1, C. Brinkman1, J. Kulinski2, A. Olivera2, A. Cartier3, T. Hla4, K. Hippen5, B. Blazar5, S. Schwab6, J. Bromberg1

    1Surgery, UMB, Baltimore, MD, 2NIH, Bethesda, MD, 3Boston Children's hospital, Boston, MA, 4Boston Children's hospital, Boston, MD, 5U.Minnesota, Minneapolis, MN, 6NYU, NY, NY

    *Purpose: CCR7 plays critical roles in T cell migration to CCL21 across lymphatic endothelial cells from tissues to lymph nodes (LN). S1PR1 and S1PR4 are…
  • 2019 American Transplant Congress

    S1PR1 and S1PR4 Regulate T Cell Migration into Afferent Lymphatics

    Y. Xiong1, W. Piao1, C. Brinkman1, L. Li1, J. Kulinski2, A. Olivera2, A. Cartier3, T. Hla4, K. Hippen5, B. Blazar6, S. Schwab7, J. Bromberg1

    1Surgery, UMB, Baltimore, MD, 2NIH, Bethesda, MD, 3Boston Children's hospital, Boston, MA, 4Boston Children's, Boston, MA, 5U.Minnesota, Minneapolis, MN, 6U.Minnesota, Minneapolis, MD, 7NYU, NY, NY

    *Purpose: T cells utilize S1PR1 to traffic from thymus into blood, and lymph nodes (LN) into efferent lymphatics. Whether T cell S1PR1 and S1PR4 regulate…
  • 2017 American Transplant Congress

    CD4 T Cell Migration Across Lymphatic Endothelium Is Enhanced by Sphingosine 1-Phosphate (S1P) and Differentially Regulated by S1P Receptors (S1PR).

    Y. Xiong,1 C. Brinkman,1 K. Hippen,2 B. Blazar,2 J. Bromberg.1

    1UMB, Baltimore; 2UM, Minneapolis

    Introduction: S1PR1 drives T cells to migrate from thymus to blood, and from lymph node (LN) to efferent lymphatics. Whether S1PR1 or other S!PRs regulate…
  • 2017 American Transplant Congress

    Evolution of Lipid Profile and Major Adverse Cardiac Events in Kidney Transplant Recipients Converted from Calcineurin Inhibitor to Everolimus: 24-Month Subanalysis from Elevate Study.

    M. van der Giet,1 J. de Fijter,1 F. Oppenheimer,1 G. Russ,1 P. Lopez,2 G. Bader,2 J. Cruzado,1 H. Holdaas.1

    1ELEVATE Study Group, Berlin, Germany; 2Novartis Pharma AG, Basel, Switzerland

    PURPOSE: Posttransplant (post-Tx) lipid abnormalities may increase risk of cardiovascular (CV) events in kidney transplant recipients (KTxR). Previous analysis from ELEVATE (NCT01114529) study confirmed that…
  • 2017 American Transplant Congress

    Lipid Catabolism Provides Alternative Energy Source and Compensates for Mitochondrial Dysfunction in Reperfused Rat Kidneys After Ischaemia.

    H. Huang,1,2 L. van Dullemen,3 M. Akhtar,1 M. Lo Faro,1,2 A. Dona,4 M. Kaisar,1,2 H. Leuvenink,3 B. Kessler,2 R. Ploeg.1

    1Oxford Transplant Centre, NDS, University of Oxford, Oxford, United Kingdom; 2Target Discovery Institute, NDM, University of Oxford, Oxford, United Kingdom; 3Department of Surgery, University Medical Center Groningen, Groningen, Netherlands; 4Department of Surgery and Cancer, Imperial College London, London, United Kingdom

    Introduction: To reduce morbidity and mortality on the wait list for kidney transplantation, centres are required to use older and higher risk organs including unstable…
  • 2017 American Transplant Congress

    Lipid Abnormalities and Cardiovascular Events After Early Conversion to Everolimus in Kidney Transplant Recipients with Pretransplant Diabetes: 24-Month Analysis from Elevate Study.

    M. van der Giet,1 J. de Fijter,1 F. Oppenheimer,1 G. Russ,1 P. Lopez,2 G. Bader,2 J. Cruzado,1 H. Holdaas.1

    1ELEVATE Study Group, Berlin, Germany; 2Novartis Pharma AG, Basel, Switzerland

    PURPOSE: Pretransplant (preTx) diabetes is an independent risk factor for cardiovascular (CV) events, and posttransplant (post-Tx) hyperlipidemia further increases CV risk. To analyze the influence…
  • 2016 American Transplant Congress

    Influence of Lipid Levels on Cardiovascular Events After Early Conversion from Calcineurin Inhibitor to Everolimus: 24 M Analysis of the ELEVATE Study.

    M. van der Giet,1 J. de Fijter,1 F. Oppenheimer,1 L. Toselli,1 G. Russ,1 P. Lopez,2 J. Aguilar,2 P. Bernhardt,2 Z. Wang,3 J. Cruzado,1 H. Holdaas.1

    1ELEVATE study group, Berlin, Germany; 2Novartis pharma AG, Basel, Switzerland; 3Novartis Pharmaceutical Corporation, East Hanover, NJ.

    Background: Immunosuppressive therapies are probably the most important cause of hyperlipidemia post-renal transplantation (RTx). Lipid abnormalities represent important biomarkers for cardiovascular (CV) risk. Here, we…
  • 2016 American Transplant Congress

    Sphingosine 1-Phosphate (S1P) Receptors Differentially Regulate Murine and Human CD4 T Cell Migration Across Lymphatic Endothelium.

    Y. Xiong,1 C. Brinkman,1 K. Hippen,2 B. Blazar,2 J. Bromberg.1

    1University of Maryland, Baltimore; 2University of Minnesota, Minneapolis.

    S1P and S1PR1 are used by T cells to migrate from thymus across microvascular endothelium to the blood circulation, and across medullary lymphatic endothelium of…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences